EAST END GROUP, LLC

Consulting and government affairs.

Filings
832
Clients
42
Total Income
$33,123,000
Years Active
2010–2026

Filings

Year Client Period Income Expenses Doc
2026 ALVOGEN 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Termination (No Activity)
$45,000
2026 FRESENIUS KABI 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Termination (No Activity)
$45,000
2026 FRESENIUS KABI 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$45,000
2026 PARTNER THERAPUTICS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2026 LONGHORN 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2026 ALVOGEN 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$45,000
2026 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$45,000
2026 BAVARIAN NORDIC INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2026 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2nd Quarter (Apr 1 - June 30)
AMENDED
$75,000
2026 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$75,000
Page 1 of 50  ·  500 filings Next

Clients Represented

ClientFilingsTotal Income
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 71 $3,570,000
BAVARIAN NORDIC INC. 68 $2,975,000
GLAXOSMITHKLINE 64 $3,520,000
AMGEN, INC, 49 $2,065,000
SEQIRUS 42 $1,755,000
NOVARTIS 42 $1,650,000
ASTRAZENECA 39 $1,825,000
BAYER CORPORATION 38 $1,320,000
ALVOGEN 37 $1,470,000
PFENEX INC. 33 $1,350,000
ALERE INC. 30 $1,260,000
AMAZON 20 $860,000
SMITH & NEPHEW 20 $825,000
MERCK & CO., INC. 18 $675,000
BIOTECHNOLOGY INDUSTRY ORGANIZATION 17 $749,000
MEDIMMUNE 16 $555,000
RAI SERVICES COMPANY 15 $540,000
FRESENIUS MEDICAL CARE NORTH AMERICA 15 $495,000
LONGHORN 14 $770,000
ALKERMES 14 $240,000

Lobbyists

NameDisclosed Prior Position
KELLY CHILDRESS LANGE Rep. Shimkus, LA; Rep. Rogers, LA.
ANDREW HAWKINS Rep. Rogers, LA; Rep. Rogers, Chief of Staff.
DAVID THOMSON MOHLER
BARRETT THORNHILL
MICHAEL PAUL WOODY Senate HELP Committee; Sen. Tom Harkin, LA; Rep. Marion Berry, LA.